Syneron Medical Completes Agreement to Enter Global Joint Venture in Home Beauty Devices

  Syneron Medical Completes Agreement to Enter Global Joint Venture in Home
                                Beauty Devices

Syneron Beauty now part of Iluminage Beauty joint venture with Unilever
Ventures

PR Newswire

YOKNEAM, Israel, Dec. 9, 2013

YOKNEAM, Israel, Dec. 9, 2013 /PRNewswire/ --Syneron Medical Ltd.
(NASDAQ:ELOS), the leading global aesthetic device company, announced today
that it has completed its previously announced agreement with Unilever
Ventures to create a global joint venture in home beauty devices. The new
joint venture, Iluminage Beauty, will develop and bring to consumers
innovative, high performance beauty solutions, empowering them with
professional level devices for at-home use.

(Logo: http://photos.prnewswire.com/prnh/20120528/535447 )

Shimon Eckhouse, Chief Executive Officer of Syneron Medical, commented, "We
believe Iluminage Beauty is well positioned to gain share in the home beauty
device market. The joint venture structure will allow us to focus on driving
growth in our professional aesthetic business while also maximizing the value
of our investment in our home-use business."

The joint venture will leverage Unilever's global experience in the
development and marketing of consumer beauty products and Syneron Medical's
expertise in professional aesthetic device technology.

About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device
company with a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide advanced
solutions for a broad range of medical-aesthetic applications including body
contouring, hair removal, wrinkle reduction, rejuvenation of the skin's
appearance through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela. Founded in 2000,
the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd.
are located in Israel. Syneron also has R&D and manufacturing operations in
the US. The Company markets and services and supports its products in 90
countries. It has offices in North America, France, Germany, Italy, Portugal,
Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

SOURCE Syneron Medical Ltd.

Website: http://investors.syneron.com
Contact: Hugo Goldman, Chief Financial Officer, + 972 73 244 2283, Email:
hugo.goldman@syneron.com; Zack Kubow, The Ruth Group, 646-536-7020, Email:
zkubow@theruthgroup.com
 
Press spacebar to pause and continue. Press esc to stop.